N-methyl-4-[[2-methyl-6-(1,3-thiazol-5-yl)-8-(trifluoromethyl)quinazolin-4-yl]amino]cyclohexane-1-carboxamide
C21H22F3N5OS — CID 118736881
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-methyl-4-[[2-methyl-6-(1,3-thiazol-5-yl)-8-(trifluoromethyl)quinazolin-4-yl]amino]cyclohexane-1-carboxamide
N-methyl-4-[[2-methyl-6-(1,3-thiazol-5-yl)-8-(trifluoromethyl)quinazolin-4-yl]amino]cyclohexane-1-carboxamide (PubChem CID 118736881) has the molecular formula C21H22F3N5OS and a molecular weight of 449.50 g/mol. Its IUPAC name is N-methyl-4-[[2-methyl-6-(1,3-thiazol-5-yl)-8-(trifluoromethyl)quinazolin-4-yl]amino]cyclohexane-1-carboxamide.
Molecular Properties
| Compound Name | N-methyl-4-[[2-methyl-6-(1,3-thiazol-5-yl)-8-(trifluoromethyl)quinazolin-4-yl]amino]cyclohexane-1-carboxamide |
|---|---|
| PubChem CID | 118736881 |
| Molecular Formula | C21H22F3N5OS |
| Molecular Weight | 449.50 g/mol |
| Exact Mass | 449.15 |
| IUPAC Name | N-methyl-4-[[2-methyl-6-(1,3-thiazol-5-yl)-8-(trifluoromethyl)quinazolin-4-yl]amino]cyclohexane-1-carboxamide |
| SMILES | CNC(=O)C1CCC(Nc2nc(C)nc3c(C(F)(F)F)cc(-c4cncs4)cc23)CC1 |
| InChI | InChI=1S/C21H22F3N5OS/c1-11-27-18-15(7-13(17-9-26-10-31-17)8-16(18)21(22,23)24)19(28-11)29-14-5-3-12(4-6-14)20(30)25-2/h7-10,12,14H,3-6H2,1-2H3,(H,25,30)(H,27,28,29) |
| InChIKey | QADCFCAKUGGZJW-UHFFFAOYSA-N |
| XLogP | 4.80 |
| TPSA | 79.80 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 449.50 |
| LogP ≤ 5 | 4.80 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118736881 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.